tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Protalix Biotherapeutics Inc

PLX
Add to Watchlist
2.395USD
+0.025+1.05%
Close 07-27 16:00（ET）Quotes delayed by 15 min
192.97MMarket Cap
12.40P/E TTM

Protalix Biotherapeutics Inc

2.395
+0.025+1.05%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

PLX Financials

See Protalix Biotherapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Protalix Biotherapeutics Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
0.23/-0.01
Revenue / Forecast
26.33M/11.47M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
52.74M
-1.23%
EPS(YoY)
-0.08
-308.02%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
585.61%0.23
-174.85%-0.07
-32.50%0.03
106.92%0.00
24.91%-0.05
211.11%0.09
271.74%0.04
-110.44%-0.03
-15.49%-0.06
-13.81%-0.08
---0.03
--0.29
---0.05
---0.07
---0.24
----
----
----
----
----
Revenue
233.73%33.75M
-49.93%9.12M
-0.60%17.85M
16.21%15.66M
169.82%10.11M
73.74%18.22M
73.60%17.96M
-61.59%13.47M
-60.91%3.75M
21.69%10.49M
-27.06%10.35M
300.72%35.08M
-40.39%9.59M
0.80%8.62M
17.66%14.18M
36.19%8.75M
42.09%16.09M
-56.15%8.55M
11.71%12.05M
-41.40%6.43M
Net Profit
606.13%18.32M
-184.76%-5.50M
-27.22%2.35M
107.44%164.00K
21.24%-3.62M
207.45%6.49M
274.73%3.24M
-111.39%-2.20M
-46.76%-4.59M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
43.90%-3.74M
15.05%-3.57M
52.55%-5.33M
58.25%-2.29M
-1779.35%-6.67M
5.36%-4.20M
-170.87%-11.24M
Net Margin
251.66%54.27%
-269.27%-60.34%
-26.78%13.19%
106.41%1.05%
70.81%-35.79%
161.84%35.65%
200.65%18.02%
-129.65%-16.35%
-275.43%-122.60%
-32.80%-57.64%
---17.90%
--55.14%
---32.66%
---43.40%
---28.67%
----
----
----
----
----
Gross Margin
359.20%87.77%
-37.25%49.36%
0.01%53.37%
109.63%62.51%
-37.49%19.11%
406.09%78.67%
1.26%53.37%
-63.84%29.82%
-54.92%30.58%
-78.47%15.54%
--52.70%
--82.47%
--67.82%
--72.18%
--55.93%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
-100.00%0.00%
-100.00%0.00%
-2.03%22.31%
-46.47%22.73%
-52.53%23.98%
--23.06%
--22.77%
--42.47%
--50.53%
--49.57%
----
----
----
----
----
Income Statement
Revenue
233.73%33.75M
-49.93%9.12M
-0.60%17.85M
16.21%15.66M
169.82%10.11M
73.74%18.22M
73.60%17.96M
-61.59%13.47M
-60.91%3.75M
21.69%10.49M
-27.06%10.35M
300.72%35.08M
-40.39%9.59M
0.80%8.62M
17.66%14.18M
36.19%8.75M
42.09%16.09M
-56.15%8.55M
11.71%12.05M
-41.40%6.43M
Operating profit
610.16%21.15M
-164.61%-4.66M
-46.60%2.13M
148.29%1.17M
14.64%-4.14M
228.39%7.21M
311.50%3.99M
-111.88%-2.43M
-97.48%-4.86M
-125.05%-5.62M
39.62%-1.89M
469.68%20.42M
-31.50%-2.46M
56.27%-2.50M
-65.78%-3.13M
39.73%-5.52M
49.53%-1.87M
-300.99%-5.71M
26.99%-1.89M
-309.20%-9.17M
Net Profit
606.13%18.32M
-184.76%-5.50M
-27.22%2.35M
107.44%164.00K
21.24%-3.62M
207.45%6.49M
274.73%3.24M
-111.39%-2.20M
-46.76%-4.59M
-61.60%-6.04M
48.08%-1.85M
462.56%19.34M
-36.96%-3.13M
43.90%-3.74M
15.05%-3.57M
52.55%-5.33M
58.25%-2.29M
-1779.35%-6.67M
5.36%-4.20M
-170.87%-11.24M
Balance Sheet
Current assets
42.70%86.36M
10.98%66.67M
38.97%66.50M
-15.36%65.48M
-19.75%60.51M
-14.09%60.08M
-34.10%47.85M
5.15%77.37M
36.11%75.40M
55.82%69.93M
58.69%72.62M
48.04%73.58M
-2.02%55.40M
-27.22%44.88M
-35.75%45.76M
-48.19%49.70M
-37.66%56.54M
10.67%61.67M
18.05%71.22M
76.95%95.92M
Total current liabilities
12.61%27.39M
3.50%26.52M
-9.39%21.95M
-58.44%24.09M
-55.64%24.32M
-43.73%25.62M
-44.14%24.22M
150.86%57.97M
73.97%54.83M
40.40%45.53M
26.40%43.36M
-25.36%23.11M
-10.80%31.52M
-2.25%32.43M
-19.79%34.30M
-67.83%30.96M
-56.31%35.33M
-61.63%33.18M
-2.58%42.76M
126.92%96.25M
Total assets
38.49%102.34M
12.16%82.35M
33.63%82.26M
-14.26%78.49M
-17.74%73.89M
-13.05%73.42M
-29.70%61.56M
3.53%91.54M
34.96%89.83M
51.35%84.43M
54.42%87.57M
45.81%88.42M
-2.68%66.56M
-24.27%55.79M
-32.07%56.71M
-43.96%60.64M
-33.47%68.39M
8.44%73.67M
15.45%83.48M
50.89%108.20M
Total liabilities
22.39%35.11M
12.94%34.12M
0.79%29.36M
-54.60%28.58M
-52.22%28.68M
-40.62%30.21M
-40.95%29.13M
27.41%62.96M
-8.41%60.04M
-23.43%50.87M
-27.70%49.32M
-29.94%49.42M
-13.61%65.55M
-16.65%66.43M
-18.07%68.22M
-32.42%70.53M
-14.06%75.88M
-16.08%79.70M
-21.17%83.27M
-1.98%104.36M
Total equity
48.71%67.23M
11.62%48.23M
63.11%52.91M
74.60%49.90M
51.78%45.21M
28.72%43.21M
-15.19%32.44M
-26.72%28.58M
2854.96%29.79M
415.50%33.57M
432.18%38.25M
494.39%39.00M
113.47%1.01M
-76.28%-10.64M
-5505.63%-11.51M
-357.46%-9.89M
-151.61%-7.49M
77.68%-6.04M
100.64%213.00K
111.05%3.84M
Cash Flow Statement
Net operating income
535.45%22.02M
-49.14%2.03M
-190.91%-3.73M
-44.96%-5.23M
-220.77%-5.06M
11.02%3.99M
159.60%4.11M
-172.59%-3.61M
239.69%4.19M
237.69%3.59M
25.16%-6.89M
167.60%4.97M
48.57%-3.00M
48.67%-2.61M
-389.57%-9.20M
-212.89%-7.36M
40.73%-5.83M
32.62%-5.09M
47.84%-1.88M
183.17%6.52M
Net investment
1453.53%4.22M
92.74%-1.11M
-102.48%-504.00K
-143.33%-438.00K
48.51%-312.00K
-4379.53%-15.32M
197.36%20.33M
18.92%-180.00K
-112.81%-606.00K
-106.90%-342.00K
-453.16%-20.88M
-162.18%-222.00K
129.11%4.73M
-86.77%4.95M
27.72%5.91M
-95.27%357.00K
47.02%-16.26M
393.10%37.44M
-40.68%4.63M
2913.43%7.54M
Net financing
-97.04%150.00K
-95.97%146.00K
100.00%0.00
--4.10M
--5.08M
--3.63M
---20.42M
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
294.74%10.43M
--14.23M
200.72%4.08M
105.85%1.52M
--2.64M
----
-186.97%-4.05M
-681.17%-25.99M
100.00%0.00

FAQs

What is the total revenue of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its total revenue reached 52.74M, with a year-on-year change of 53.40M.

What are the current assets of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its current assets were 66.67M, with a year-on-year change of 10.98.

What are the total assets of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its total assets of Protalix Biotherapeutics Inc were 82.35M, with a year-on-year change of 12.16.

What are the total liabilities of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its total liabilities of Protalix Biotherapeutics Inc were 34.12M, with a year-on-year change of 12.94.

What is the total equity of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its total equity of Protalix Biotherapeutics Inc was 48.23M, with a year-on-year change of 11.62.

What is the net operating income of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its net operating income of Protalix Biotherapeutics Inc was -5.50M, with a year-on-year change of -240.41.

What is the net investment of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its net investment of Protalix Biotherapeutics Inc was -2.37M, with a year-on-year change of -156.05.

What is the net financing of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its net financing of Protalix Biotherapeutics Inc was 9.33M, with a year-on-year change of 155.53.

What is the Earnings Per Share (EPS) of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.08, with a year-on-year change of -308.02.

What is the net income of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its net income was -6.60M, with a year-on-year change of -325.24.

What is the net margin of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its net profit margin was -12.52, with a year-on-year change of -328.04.

What is the gross margin of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its gross margin was 48.82, with a year-on-year change of -10.35.

What is the Return on Equity (ROE) of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -14.44, with a year-on-year change of -289.13.

What is the Return on Assets (ROA) of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -8.48, with a year-on-year change of -328.26.

What is the operating profit of Protalix Biotherapeutics Inc?

According to Protalix Biotherapeutics Inc's FY2025 earnings report, its operating profit was -5.50M, with a year-on-year change of -240.41.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy